BNP Paribas Financial Markets
BNR

BNP Paribas Financial Markets’s Burning Rock Biotech BNR Stock Holding History

BNP Paribas Financial Markets’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.1K Hold
2,800
– – ﹤0.01% 4747
2025
Q4 		$56.4K Buy
2,800
+1,900
+211% +$27.7K ﹤0.01% 4627
2025
Q3 		$7.79K Hold
900
– – ﹤0.01% 5049
2025
Q2 		$2.84K Buy
900
+100
+13% +$310 ﹤0.01% 5017
2025
Q1 		$3.6K Hold
800
– – ﹤0.01% 4906
2024
Q4 		$5.4K Buy
+800
New +$3.69K ﹤0.01% 4926

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
CL
CRCM LP San Francisco, California $141M AUM 153.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RWMG
Redwood Wealth Management Group Medford, New Jersey $232M AUM 22.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

BNP Paribas Financial Markets's BNR Position: Q1 2026 in Review

BNP Paribas Financial Markets held its Burning Rock Biotech (BNR) position steady in Q1 2026 at 2,800 shares worth $45.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4747.

BNP Paribas Financial Markets first reported a position in BNR in Q4 2024 and has held it in 6 quarters since. The position peaked at $56.4K in Q4 2025. 16 funds tracked by Wall St. Rank hold BNR as of Q1 2026.

  • BNP Paribas Financial Markets held 2,800 shares of Burning Rock Biotech worth $45.1K as of Q1 2026.
  • BNP Paribas Financial Markets left its Burning Rock Biotech share count unchanged in Q1 2026.
  • Burning Rock Biotech made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4747 holding.
  • BNP Paribas Financial Markets first reported a position in Burning Rock Biotech in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's Burning Rock Biotech position peaked at $56.4K in Q4 2025.
  • 16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.